Cargando…

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

Fibroblast growth factor-23 (FGF)-23 is a phosphaturic hormone involved in mineral bone metabolism that helps control phosphate homeostasis and reduces 1,25-dihydroxyvitamin D synthesis. Recent data have highlighted the relevant direct FGF-23 effects on the myocardium, and high plasma levels of FGF-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez-Sánchez, Sara, Poveda, Jonay, Navarro-García, José Alberto, González-Lafuente, Laura, Rodríguez-Sánchez, Elena, Ruilope, Luis M., Ruiz-Hurtado, Gema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985069/ https://www.ncbi.nlm.nih.gov/pubmed/33767635 http://dx.doi.org/10.3389/fphys.2021.632260

Ejemplares similares

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: Navarro-García, José Alberto, et al.
Publicado: (2021)

Partial Genetic Deletion of Klotho Aggravates Cardiac Calcium Mishandling in Acute Kidney Injury
por: González-Lafuente, Laura, et al.
Publicado: (2023)

Oxidized Low-Density Lipoprotein Associates with Ventricular Stress in Young Adults and Triggers Intracellular Ca(2+) Alterations in Adult Ventricular Cardiomyocytes
por: Rodríguez-Sánchez, Elena, et al.
Publicado: (2020)

Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
por: Radloff, Judith, et al.
Publicado: (2021)

FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

FGF23 level in poultry chicken, a systematic review and meta-analysis
por: Poorhemati, Hossein, et al.
Publicado: (2023)

The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
por: van Vuren, Annelies J., et al.
Publicado: (2019)

Twist1-Haploinsufficiency Selectively Enhances the Osteoskeletal Capacity of Mesoderm-Derived Parietal Bone Through Downregulation of Fgf23
por: Quarto, Natalina, et al.
Publicado: (2018)

FGF23 and Phosphate–Cardiovascular Toxins in CKD
por: Vogt, Isabel, et al.
Publicado: (2019)

FGF-23 protects cell function and viability in murine pancreatic islets challenged by glucolipotoxicity
por: Pajaziti, Betina, et al.
Publicado: (2022)

The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23
por: Navarro-García, José Alberto, et al.
Publicado: (2022)

Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D(3) treatment
por: Hanai, Ayako, et al.
Publicado: (2023)

Age and blood pressure goal in women with prior coronary events
por: Ruilope, Luis M., et al.
Publicado: (2020)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Systemic lupus erythematosus and cardiovascular disease
por: Ruilope, Luis M., et al.
Publicado: (2020)

Myostatin regulates the production of fibroblast growth factor 23 (FGF23) in UMR106 osteoblast–like cells
por: Ewendt, Franz, et al.
Publicado: (2021)

Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration
por: Navarro-García, José Alberto, et al.
Publicado: (2019)

Editorial: Contribution of Uremic Compounds to Cardiorenal Syndrome Development
por: Carneiro-Ramos, Marcela Sorelli, et al.
Publicado: (2022)

MAP4 as a New Candidate in Cardiovascular Disease
por: Li, Lingfei, et al.
Publicado: (2020)

Editorial: Evolving Picture of Calcium Handling in Cardiac Disease
por: Ruiz-Hurtado, Gema, et al.
Publicado: (2020)

Pathophysiological roles of FGF signaling in the heart
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Altered GDF15 and FGF21 Levels in Response to Strenuous Exercise: A Study in Marathon Runners
por: Campderrós, Laura, et al.
Publicado: (2020)

Nano-Messengers of the Heart: Promising Theranostic Candidates for Cardiovascular Maladies
por: Yedavilli, Sneha, et al.
Publicado: (2022)

The other side of cardiac Ca(2+) signaling: transcriptional control
por: Domínguez-Rodríguez, Alejandro, et al.
Publicado: (2012)

FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018)

The impact of antihypertensives on kidney disease
por: Marquez, Diego F, et al.
Publicado: (2017)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Unilateral Acute Renal Ischemia-Reperfusion Injury Induces Cardiac Dysfunction through Intracellular Calcium Mishandling
por: Junho, Carolina Victoria Cruz, et al.
Publicado: (2022)

FGF21 as Modulator of Metabolism in Health and Disease
por: Tezze, Caterina, et al.
Publicado: (2019)

Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011)

FGF23 and inflammation
por: Sharaf El Din, Usama A A, et al.
Publicado: (2017)

Gender-Dependent Alteration of Ca(2+) and TNFα Signaling in db/db Mice, an Obesity-Linked Type 2 Diabetic Model
por: Delgado, Carmen, et al.
Publicado: (2019)

Time-Dependent Changes of Klotho and FGF-23 Levels after Kidney Transplantation: Role of Cold Ischemia Time, Renal Function and Graft Inflammation
por: Vazquez-Sanchez, Teresa, et al.
Publicado: (2023)

FGF23 and its role in X-linked hypophosphatemia-related morbidity
por: Beck-Nielsen, Signe Sparre, et al.
Publicado: (2019)

Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9–Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA Technology: A New Alternative to Classical ELISA
por: Pulido-Olmo, Helena, et al.
Publicado: (2017)

Corrigendum: FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018)

Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis
por: Elfimova, Natalia, et al.
Publicado: (2012)

Mathematical biomarkers for the autonomic regulation of cardiovascular system
por: Campos, Luciana A., et al.
Publicado: (2013)

Microalbuminuria and cardiorenal risk: old and new evidence in different populations
por: Márquez, Diego Francisco, et al.
Publicado: (2019)

FGF-23 in bone biology
por: Wesseling-Perry, Katherine
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h1egdkog4rksou7u1bfom2cd9e